Chattem Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHATTEM, and when can generic versions of CHATTEM drugs launch?
CHATTEM has twenty approved drugs.
There are two US patents protecting CHATTEM drugs.
There are sixty-seven patent family members on CHATTEM drugs in forty countries and two supplementary protection certificates in two countries.
Summary for Chattem
| International Patents: | 67 |
| US Patents: | 2 |
| Tradenames: | 17 |
| Ingredients: | 9 |
| NDAs: | 20 |
Drugs and US Patents for Chattem
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chattem Sanofi | GAVISCON | aluminum hydroxide; magnesium trisilicate | TABLET, CHEWABLE;ORAL | 018685-002 | Dec 9, 1983 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Chattem Sanofi | GAVISCON | aluminum hydroxide; magnesium trisilicate | TABLET, CHEWABLE;ORAL | 018685-001 | Dec 9, 1983 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Chattem Sanofi | ALLEGRA | fexofenadine hydrochloride | CAPSULE;ORAL | 020625-001 | Jul 25, 1996 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Chattem
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Chattem Sanofi | ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION | fexofenadine hydrochloride; pseudoephedrine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021704-002 | Jan 24, 2011 | 6,037,353*PED | ⤷ Subscribe |
| Chattem Sanofi | ALLEGRA ALLERGY | fexofenadine hydrochloride | TABLET;ORAL | 020872-007 | Jan 24, 2011 | 5,855,912*PED | ⤷ Subscribe |
| Chattem Sanofi | ALLEGRA HIVES | fexofenadine hydrochloride | TABLET;ORAL | 020872-009 | Jan 24, 2011 | 6,399,632*PED | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for CHATTEM drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Transdermal System | 7 mg/24 hrs, 14 mg/24 hrs, and 21 mg/24 hrs | ➤ Subscribe | 2014-05-30 |
| ➤ Subscribe | Tablets | 5 mg | ➤ Subscribe | 2007-12-17 |
| ➤ Subscribe | Oral Suspension | 30 mg/5 mL | ➤ Subscribe | 2010-01-25 |
| ➤ Subscribe | Oral Solution | 0.5 mg/mL | ➤ Subscribe | 2009-01-14 |
| ➤ Subscribe | Tablets | 150 mg | ➤ Subscribe | 2007-10-30 |
International Patents for Chattem Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 1768649 | ⤷ Subscribe |
| Peru | 20071003 | ⤷ Subscribe |
| South Korea | 20080074180 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Chattem Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0058146 | 2001C/045 | Belgium | ⤷ Subscribe | PRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103 |
| 0663828 | C300085 | Netherlands | ⤷ Subscribe | PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
